Illumina's CEO Promises Growth By 2027, Because Patience Is A Strategy
Jacob Thaysen, Illumina's fearless captain navigating the turbulent biotech seas, insists they're still on course for a modest 'high single-digit revenue growth' by the distant shores of 2027. Despite unexpected headwindsâlikely a fancy euphemism for market chaos, supply chain mayhem, or maybe his coffee machine breakingâthe CEO remains optimistic. Illumina, known for turning DNA into some kind of money magic, apparently believes five more years of slow growth is an acceptable life strategy. It's 2024, investors might just want to pop some popcorn and enjoy the slowest rollercoaster ride in corporate history.
Share the Story
Illuminaâs CEO is basically telling investors, 'Hang tight, itâs a glacier-speed race to glory by 2027,' because nothing screams excitement like three years to reach what a startup might pull off in six months.
Who needs quarterly fireworks when you can watch Illuminaâs revenue growth crawl at a snailâs pace through 2027? CEO must think investors love suspenseful slow burns.
Illuminaâs strategy: convince Wall Street that waiting for 'high single-digit growth' five years from now is a thrilling binge-watch, not a patience test.
Source: Statnews | Published: 8/26/2025 | Author: Jonathan Wosen
More Articles in Business
Laura Danger Declares Emotional Labor Is Real Work, Not Invisible Magic
CES 2026: The Worldâs Largest Tech Flex in the Las Vegas Desert
America Adds 50,000 Jobs, But Those 70,000 Stayed Home for Holidays
Billionaire Bros Move T-Rex LLC Out of California to Avoid Paying Taxes; Dinosaur Surprised
Grandfather Gifts $1,500 with Guest Star Role for Financial Advisor
Facebook Exec Jumps Off Career Cliff to Build Giant iPhone Flop
Man Moves to Spain for Sun, Pays in Airport Commute Hours Instead of Pounds
New Berkshire CEO Gets $25M While Buffett Lived on $100K and Sandwiches
